Lantheus Holdings LNTH
NASDAQ LNTH
$99.97 -0.27 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lantheus Holdings (LNTH) Change in Acquisitions & Divestments (2016)

Lantheus Holdings (LNTH) posted quarterly Change in Acquisitions & Divestments of $74000.0 for Q1 2016.

Lantheus Holdings (LNTH) Change in Acquisitions & Divestments (2016) Analysis & Trends

Lantheus Holdings (LNTH) has reported Change in Acquisitions & Divestments for 1 consecutive years, with $74000.0 the latest figure, recorded in Q1 2016.

  • In Q1 2016, Change in Acquisitions & Divestments changed N/A year-over-year to $74000.0; the TTM figure through Dec 2016 stood at $74000.0 (changed N/A YoY), while the FY2016 annual figure was $74000.0, changed N/A from the prior year.
  • Change in Acquisitions & Divestments held at $74000.0 in Q1 2016 per LNTH's latest filing.
  • Across five years, Change in Acquisitions & Divestments topped out at $74000.0 in Q1 2016 and bottomed at $74000.0 in Q1 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 44.51 Bn 43.55 Bn -
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn -
10 Lantheus Holdings 6.52 Bn 5.93 Bn 241.86 Mn

Historic Data

Download Data
DateValue
Mar 31, 2016 74,000.00
Mar 31, 2016 74,000.00